Randomized Clinical Trial of the Effects of Perioperative Use of Immune‐enhancing Enteral Formula on Metabolic and Immunological Status in Patients Undergoing Esophagectomy

Abstract

Perioperative use of IEEF caused a significant increase in the total lymphocyte count at 3 and 5 days after operation and caused a shift toward B cell proliferation, which may possibly be beneficial to decrease the incidence of postoperative infectious complications.